Literature DB >> 23058037

Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Tehreem F Butt1, Anthony R Cox, Jan R Oyebode, Robin E Ferner.   

Abstract

BACKGROUND: Life-threatening adverse drug reactions (ADRs) such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) continue to affect patients' lives long after the event. Survivors and their relatives rely heavily on Internet sources for support and advice, but narratives of their experiences posted on patient websites have not been explored previously.
OBJECTIVES: The aim of the study was to illuminate patient experience by analysing Internet narratives of drug-induced SJS and TEN and considering the reasons for postings on patient websites, and the concerns they reflect. We also aimed to compare these experiences with a previous study of survivors of SJS and TEN conducted by face-to-face interview.
METHODS: We searched for unsolicited personal narratives or descriptions of drug-induced SJS and TEN posted on the Internet between February 2009 and June 2010, and analysed them using a thematic qualitative approach.
RESULTS: We analysed 208 Internet descriptions. Motivation for posting on the Internet included a desire to share experiences and to seek advice from others. Patients and their relatives expressed concern that the ADR may be hereditary, worries about effects on fertility and a fear of recurrence. They also wished to increase awareness of the potential harms from medicines and to inform others of the suspected cause of the ADR.
CONCLUSION: Individuals experiencing SJS or TEN had many unanswered questions and concerns long after the event. Our findings could guide health professionals in the management of survivors of the ADR, and in communicating more effectively with patients and their relatives. Internet forum postings of patient experiences of ADRs provide insight into patient concerns and supplement findings from detailed face-to-face interviews.

Entities:  

Mesh:

Year:  2012        PMID: 23058037     DOI: 10.1007/bf03262001

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  21 in total

1.  Living with HIV/AIDS and use of online support groups.

Authors:  Phoenix K H Mo; Neil S Coulson
Journal:  J Health Psychol       Date:  2010-04

Review 2.  The role of the Internet in supporting and informing carers of people with cancer: a literature review.

Authors:  Nicole A Kinnane; Donna J Milne
Journal:  Support Care Cancer       Date:  2010-03-25       Impact factor: 3.603

3.  Exploring the communication of social support within virtual communities: a content analysis of messages posted to an online HIV/AIDS support group.

Authors:  Phoenix K H Mo; Neil S Coulson
Journal:  Cyberpsychol Behav       Date:  2008-06

4.  Diagnosis in general practice. Self diagnosis.

Authors:  Clare Goyder; Ann McPherson; Paul Glasziou
Journal:  BMJ       Date:  2009-11-11

5.  Content analysis of cancer blog posts.

Authors:  Sujin Kim
Journal:  J Med Libr Assoc       Date:  2009-10

6.  Patient experiences of serious adverse drug reactions and their attitudes to medicines: a qualitative study of survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK.

Authors:  Tehreem F Butt; Anthony R Cox; Helen Lewis; Robin E Ferner
Journal:  Drug Saf       Date:  2011-04-01       Impact factor: 5.606

Review 7.  Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding.

Authors:  Lars E French
Journal:  Allergol Int       Date:  2006-03       Impact factor: 5.836

8.  How breast cancer patients want to search for and retrieve information from stories of other patients on the internet: an online randomized controlled experiment.

Authors:  Regina Overberg; Wilma Otten; Andries de Man; Pieter Toussaint; Judith Westenbrink; Bertie Zwetsloot-Schonk
Journal:  J Med Internet Res       Date:  2010-03-09       Impact factor: 5.428

9.  Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.

Authors:  S Bastuji-Garin; B Rzany; R S Stern; N H Shear; L Naldi; J C Roujeau
Journal:  Arch Dermatol       Date:  1993-01

Review 10.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

View more
  16 in total

1.  Lessons Learned Designing and Using an Online Discussion Forum for Care Coordinators in Primary Care.

Authors:  Jeanne M Ferrante; Asia Friedman; Eric K Shaw; Jenna Howard; Deborah J Cohen; Laleh Shahidi
Journal:  Qual Health Res       Date:  2016-07-11

2.  The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.

Authors:  Priya Bahri; Alexander N Dodoo; Brian D Edwards; I Ralph Edwards; Irene Fermont; Ulrich Hagemann; Kenneth Hartigan-Go; Bruce Hugman; Peter G Mol
Journal:  Drug Saf       Date:  2015-07       Impact factor: 5.606

3.  Adverse drug reactions: when the risk becomes a reality for patients.

Authors:  Anthony R Cox; Tehreem F Butt
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

4.  Stevens-Johnson Syndrome and toxic epidermal necrolysis: improving the support to victims.

Authors:  Jean-Claude Roujeau
Journal:  Drug Saf       Date:  2013-02       Impact factor: 5.606

5.  Psychotherapeutic interventions for burns patients and the potential use with Stevens-Johnson syndrome and toxic epidermal necrolysis patients: A systematic integrative review.

Authors:  Pauline O'Reilly; Pauline Meskell; Barbara Whelan; Catriona Kennedy; Bart Ramsay; Alice Coffey; Donal G Fortune; Sarah Walsh; Saskia Ingen-Housz-Oro; Christopher B Bunker; Donna M Wilson; Isabelle Delaunois; Liz Dore; Siobhan Howard; Sheila Ryan
Journal:  PLoS One       Date:  2022-06-27       Impact factor: 3.752

Review 6.  Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0).

Authors:  Abhyuday Jagannatha; Feifan Liu; Weisong Liu; Hong Yu
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

7.  Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  Swapna S Shanbhag; Leangelo Hall; James Chodosh; Hajirah N Saeed
Journal:  Ocul Surf       Date:  2020-03-19       Impact factor: 5.033

Review 8.  SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.

Authors:  Katie D White; Riichiro Abe; Michael Ardern-Jones; Thomas Beachkofsky; Charles Bouchard; Bruce Carleton; James Chodosh; Ricardo Cibotti; Robert Davis; Joshua C Denny; Roni P Dodiuk-Gad; Elizabeth N Ergen; Jennifer L Goldman; James H Holmes; Shuen-Iu Hung; Mario E Lacouture; Rannakoe J Lehloenya; Simon Mallal; Teri A Manolio; Robert G Micheletti; Caroline M Mitchell; Maja Mockenhaupt; David A Ostrov; Rebecca Pavlos; Munir Pirmohamed; Elena Pope; Alec Redwood; Misha Rosenbach; Michael D Rosenblum; Jean-Claude Roujeau; Arturo P Saavedra; Hajirah N Saeed; Jeffery P Struewing; Hirohiko Sueki; Chonlaphat Sukasem; Cynthia Sung; Jason A Trubiano; Jessica Weintraub; Lisa M Wheatley; Kristina B Williams; Brandon Worley; Wen-Hung Chung; Neil H Shear; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jan - Feb

Review 9.  Systematic review on the prevalence, frequency and comparative value of adverse events data in social media.

Authors:  Su Golder; Gill Norman; Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2015-09-16       Impact factor: 4.335

10.  Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies.

Authors:  Preciosa M Coloma; Benedikt Becker; Miriam C J M Sturkenboom; Erik M van Mulligen; Jan A Kors
Journal:  Drug Saf       Date:  2015-10       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.